Takeda Pharmaceutical Ownership | Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical Ownership Summary

Takeda Pharmaceutical is owned by 1.25% institutional investors, and 98.75% retail investors. Capital research global investors is the largest institutional shareholder, holding 0.43% of TAK shares. American Funds American Mutual A is the top mutual fund, with 0.57% of its assets in Takeda Pharmaceutical shares.

TAK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Takeda Pharmaceutical	1.25%	-	98.75%
Sector	Healthcare Stocks	232.86%	10.65%	-143.51%
Industry	Specialty & Generic Drug Manufacturers Stocks	20.25%	11.78%	67.97%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Capital research global investors	13.49M	0.43%	$210.26M
Morgan stanley	6.37M	0.20%	$99.36M
Goldman sachs group	4.80M	0.15%	$74.90M
Fmr	4.19M	0.13%	$61.30M
Ubs group	4.12M	0.13%	$64.29M
Brandes investment partners, lp	3.88M	0.12%	$60.52M
Toronto dominion bank	3.00M	0.10%	$43.98M
Blackrock	1.44M	0.09%	$18.59M
Arrowstreet capital, limited partnership	2.83M	0.09%	$41.41M
Blackrock funding, inc. /de	2.73M	0.09%	$42.59M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Managed asset portfolios	1.50M	2.82%	$23.32M
Clean yield group	238.37K	1.24%	$4.41M
Legacy wealth asset management	165.80K	0.75%	$3.07M
Gold investment management	111.30K	0.64%	$2.06M
Brandes investment partners, lp	3.88M	0.46%	$60.52M
Carrera capital advisors	160.36K	0.42%	$2.50M
Bridgefront capital	83.73K	0.36%	$1.23M
Corient ia	25.00K	0.27%	$366.00K
Arjuna capital	61.00K	0.23%	$950.94K
Bayforest capital	10.29K	0.21%	$190.59K

Top Buyers

Holder	Shares	% Assets	Change
Toronto dominion bank	3.00M	0.07%	3.00M
Arrowstreet capital, limited partnership	2.83M	0.03%	1.61M
Qube research	1.78M	0.03%	1.43M
Cowen and company	530.60K	0.19%	530.60K
Northwestern mutual wealth management	259.08K	0.03%	255.69K

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-2.53M
Ubs group	4.12M	0.01%	-1.77M
Millennium management	246.66K	0.00%	-1.75M
Morgan stanley	6.37M	0.01%	-1.32M
Renaissance	2.62M	0.06%	-1.25M

New Positions

Holder	Shares	% Assets	Change	Value
Cowen and company	530.60K	0.19%	530.60K	$6.87M
Voloridge investment management	82.21K	0.00%	82.21K	$1.20M
Aquatic capital management	45.96K	0.01%	45.96K	$672.84K
Acadian asset management	28.34K	0.00%	28.34K	$441.00K
Equitable	19.48K	0.00%	19.48K	$285.23K

Sold Out

Holder	Change
Rise advisors	-1.00
Northwest financial advisors	-1.00
West branch capital	-3.00
Point72 asia (singapore) pte.	-3.00
Bogart wealth	-7.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	209	-37.61%	39,526,007	-53.64%	1	16.85%	82	-58.16%	84	12.00%
Sep 30, 2025	203	-33.88%	18,053,624	-72.33%	-	3.49%	110	-39.56%	45	-28.57%
Jun 30, 2025	309	-0.32%	77,823,025	9.47%	4	24.04%	185	9.47%	63	-29.21%
Mar 31, 2025	3	-98.99%	4,050,360	-94.38%	-	1.24%	2	-98.64%	1	-98.94%
Dec 31, 2024	182	-40.13%	33,476,783	-56.07%	2	9.19%	84	-48.47%	58	-31.76%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds American Mutual A	18.16M	0.57%	5.27M
Capital Group American Mutual Comp	18.16M	0.57%	5.27M
VanEck Pharmaceutical ETF	2.21M	0.07%	-
First Trust Value Line® Dividend ETF	1.90M	0.06%	-
Capital Group American Mutual Trust U0	946.32K	0.03%	347.59K
MAP Global Equity Composite	902.12K	0.03%	167.32K
Amplify CWP International Enh Div IncETF	886.84K	0.03%	-
Mondrian Int Eq Delivered Strategy	816.00K	0.03%	-1.77M
Steward Values Enhanced International I	711.87K	0.02%	-3.50K
Steward International Enhanced Index I	651.53K	0.02%	315.75K

Insider Transactions Trends

Date	Buy	Sell
2028 Q2	-	-
2028 Q1	-	-
2026 Q1	-	-
2022 Q4	-	-

TAK Ownership FAQ

Who Owns Takeda Pharmaceutical?

Takeda Pharmaceutical shareholders are primarily institutional investors at 1.25%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Takeda Pharmaceutical's industry, Specialty & Generic Drug Manufacturers Stocks, is 20.25%, which Takeda Pharmaceutical falls below.

Who owns the most shares of Takeda Pharmaceutical?

Takeda Pharmaceutical’s largest shareholders are Capital research global investors (13.49M shares, 0.43%), Morgan stanley (6.37M shares, 0.20%), and Goldman sachs group (4.8M shares, 0.15%). Together, they hold 0.78% of Takeda Pharmaceutical’s total shares outstanding.

Does Blackrock own Takeda Pharmaceutical?

Yes, BlackRock owns 0.09% of Takeda Pharmaceutical, totaling 1.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 18.59M$. In the last quarter, BlackRock decreased its holdings by -558K shares, a -27.99% change.

Who is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested?

Managed asset portfolios is Takeda Pharmaceutical’s biggest shareholder by percentage of total assets invested, with 2.82% of its assets in 1.5M Takeda Pharmaceutical shares, valued at 23.32M$.

Who is the top mutual fund holder of Takeda Pharmaceutical shares?

American Funds American Mutual A is the top mutual fund holder of Takeda Pharmaceutical shares, with 0.57% of its total shares outstanding invested in 18.16M Takeda Pharmaceutical shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools